Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Cardiology
Cardiovascular disease
Questions discussed in this category
Is there any difference in the cardiovascular risk reduction profile of brand name vascepa versus generic icosapent ethyl for patients with hypertriglyceridemia?
1 Answer available
21917
Papers discussed in this category
The New England journal of medicine, 2019-01-03
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
Related Topics in Cardiology
Lung Cancer
Breast Cancer
Hematologic Malignancies
Radiation Oncology
Gynecologic Oncology
Palliation
Gastrointestinal Cancers
Genitourinary Cancers
Pediatric Hematology/Oncology
Radiation Physics